Understanding how tRNA affects pancreatic cancer outcomes
Investigating tRNA biology as a prognostic and oncogenic feature in pancreatic adenocarcinoma
This study is looking at how certain types of tRNA might affect the growth and treatment response of pancreatic cancer, with the goal of finding new ways to help patients get better care tailored to their specific cancer.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11001096 on NIH RePORTER |
What this research studies
This research investigates the role of transfer RNA (tRNA) in pancreatic ductal adenocarcinoma (PDAC), a type of pancreatic cancer that is challenging to treat. The study aims to explore how variations in tRNA can influence the behavior of cancer cells, particularly their growth and response to treatments. By examining the relationship between tRNA levels and the molecular characteristics of PDAC, researchers hope to identify new prognostic markers and therapeutic targets. Patients may benefit from insights that could lead to more effective treatment strategies based on their specific cancer subtype.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic ductal adenocarcinoma.
Not a fit: Patients with other types of cancer or those without a diagnosis of pancreatic cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prognostic tools and targeted therapies for patients with pancreatic cancer.
How similar studies have performed: Previous research has shown promising results in understanding the role of tRNA in cancer biology, suggesting that this approach could yield valuable insights.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Kawalerski, Ryan — Johns Hopkins University
- Study coordinator: Kawalerski, Ryan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.